Overview
Jose co-founded Univercells in 2013 alongside Hugues Bultot and served as CTO before founding Quantoom Biosciences in 2021 to focus specifically on scalable RNA production. Quantoom received USD 13.9 million (EUR 12.4 million) in grant funding to develop its mRNA manufacturing platform for vaccines and therapeutics.
The Nfinity platform covers DNA (Nplify), RNA (Ntensify), and formulation (Ncapsulate) manufacturing, providing a full-stack RNA partner from sequence to large-scale GMP production. Quantoom has established facilities in Belgium and France and has entered partnerships with eTheRNA immunotherapies and Stevanato Group.
Career history
In the news
- The 27th Developing Countries Vaccine Manufacturers Network (DCVMN International) Annual General Meeting brings together the alliance of vaccine manufacturers from developing countries, producers whose capacity determines how fast a region can respond to its own outbreaks, rather than depending on supply decided elsewhere. Jose Castillo, our CEO, and Maria Davila-Saignol, our Director Global South & Asia Pacific, will be there from 22 to 24 September. If building RNA manufacturing capability is on your roadmap, come and talk to
- PRESS RELEASE: We are proud to share a major milestone in mRNA vaccine manufacturing and epidemic preparedness! Quantoom Biosciences Ntensify® technology for RNA production and purification is being used for Brazil's first mRNA vaccine, developed on Fiocruz own mRNA platform, which has just received authorization from Anvisa (Brazilian Health Regulatory Agency) to begin clinical trials. This milestone highlights the power of combining: 🔹 Fiocruz's leadership as the first WHO Global mRNA Technology Transfer Programme partner
- Day 1 at the 2026 Animal Health Summit in Kansas City was fantastic! Great energy, sharp conversations, and a room full of people who share our conviction: RNA has a major role to play in the future of animal health. Jose Castillo and Dr Hilde Vrancken had wonderful exchanges with animal health leaders about how our N-Force toolbox can accelerate the development of next-generation veterinary vaccines and therapeutics. We're here again today! Come say hi and let's talk about what RNA can do for your animal health pipeline. 👉 More
- Quantoom Biosciences is heading to the 2026 Animal Health Summit, hosted by the KC Animal Health Corridor. 🗓️ August 31 – September 1 | 📍 Kansas City, USA Known as the world's premier gathering of animal health leaders, the Summit brings together two days of high-impact networking, investor discussions, and business partnering at the heart of the global animal health industry. Come meet Jose Castillo, CEO and Dr Hilde Vrancken, Animal Health Business Development & Clinical Science on site. 👉 More about the Summit:
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.